MDLN

MKT CAP:$36B

Medline Inc.

Market Cap

$36B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$45.14+$4.52 (+11.13%)

Apr 24, 2026

Company Details

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline ...

CEO

James Boyle

IPO Date

Dec 17, 2025

Website

www.medline.com

Key Metrics TTM

Revenue

$28.4B

— YoY

Net Income

$1.2B

EPS (Diluted)

$1.45

Free Cash Flow

$1.7B

Revenue / Share

$35.01

Gross Margin

24.6%

Operating Margin

7.8%

Net Margin

4.1%

FCF Margin

6.1%

P/S

1.3x

P/E

31.5x

Earnings Reports

Q1 2026

May 6, 2026

PENDING

FY 2025

Dec 31, 2025

$28.4B+11.5%EPS $1.43

Q4 2025

Dec 31, 2025

$7.8BEPS $0.22

Q3 2025

Sep 29, 2025

$7.1B+11.4%EPS $0.41

Q2 2025

Jun 29, 2025

$6.9B+11.3%EPS $0.42

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 24	$6.2B	$1.5B	$516M
Q3 24	$6.4B	$1.6B	$574M
Q1 25	$6.6B	$1.6B	$591M
Q2 25	$6.9B	$1.7B	$629M
Q3 25	$7.1B	$1.7B	$574M
Q4 25	$7.8B	$1.9B	$425M

Valuation

Quarter	P/S	P/E
Q2 24	—	—
Q3 24	—	—
Q1 25	—	—
Q2 25	28.3x	580.5x
Q3 25	27.3x	567.1x
Q4 25	25.8x	634.9x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 24	$722M	$615M
Q1 25	$636M	$535M
Q2 25	$243M	$103M
Q3 25	$636M	$535M
Q4 25	$229M	$571M

Capital Expenditures

Quarter	CapEx
Q3 24	$107M
Q1 25	$101M
Q2 25	$140M
Q3 25	$101M
Q4 25	$342M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 25	+15.0%	+15.4%
Q4 25	+21.9%	+26.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 24	$0	0.0%
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	SG&A
Q2 24	$976M
Q3 24	$988M
Q1 25	$1.1B
Q2 25	$1.1B
Q3 25	$1.1B
Q4 25	$1.3B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 25	$0	$0	$0
Q2 25	$584M	$0	$584M
Q3 25	$955M	$0	$955M
Q4 25	$1.9B	$0	$1.9B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 24	787M	—	—
Q3 24	787M	0.0%	—
Q1 25	800M	+1.6%	—
Q2 25	787M	-1.6%	—
Q3 25	787M	0.0%	0.0%
Q4 25	812M	+3.2%	+3.2%

Shares Outstanding